Amide of Lambertian Acid Suppresses Hyperactivation of Inotropic Glutamate Receptors, but not Synaptic Potentiation in Hippocampal Sections

[1]  Puneet Kumar,et al.  Excitotoxicity: bridge to various triggers in neurodegenerative disorders. , 2013, European journal of pharmacology.

[2]  C. Bondi,et al.  Glutamatergic animal models of schizophrenia. , 2012, Current pharmaceutical design.

[3]  L. Gowtham,et al.  THE ROLE OF EXCITATORY NEUROTRANSMITTER GLUTAMATE IN BRAIN PHYSIOLOGY AND PATHOLOGY , 2012 .

[4]  Ann Marie Craig,et al.  NMDA Receptor Subunits Have Differential Roles in Mediating Excitotoxic Neuronal Death Both In Vitro and In Vivo , 2007, The Journal of Neuroscience.

[5]  M. Bullock,et al.  The effect of the selective NMDA receptor antagonist traxoprodil in the treatment of traumatic brain injury. , 2005, Journal of neurotrauma.

[6]  Yu. V. Kharitonov,et al.  Neurotropic activity of lambertianic acid adducts with N-substituted maleinimides , 2004, Pharmaceutical Chemistry Journal.

[7]  E. Nisenbaum,et al.  AMPA receptor potentiators for the treatment of CNS disorders. , 2004, Current drug targets. CNS and neurological disorders.

[8]  A. Belger,et al.  NMDA receptor antagonist effects, cortical glutamatergic function, and schizophrenia: toward a paradigm shift in medication development , 2003, Psychopharmacology.

[9]  G. Tolstikov,et al.  Lambertian acid and its amino derivatives: a new group of perspective neurotropic agents. , 2000, Doklady biological sciences : proceedings of the Academy of Sciences of the USSR, Biological sciences sections.

[10]  R. Dingledine,et al.  The glutamate receptor ion channels. , 1999, Pharmacological reviews.

[11]  Wilkie A. Wilson,et al.  Magnesium-free medium activates seizure-like events in the rat hippocampal slice , 1986, Brain Research.

[12]  J. Nicholls.  From neuron to brain , 1976 .